US Patent Issued to INBIOMOTION on Feb. 25 for "Therapeutic treatment of breast cancer based on c-MAF status" (British, Spanish Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,077, issued on Feb. 25, was assigned to INBIOMOTION S.L. (Barcelona, Spain).

"Therapeutic treatment of breast cancer based on c-MAF status" was invented by Walter Martin Gregory (Ilkley, Great Britain), Juan Carlos Tercero (Madrid), Robert E. Coleman (Sheffield, Great Britain) and Roger Gomis (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding, treating or preventing bone degradation. I...